<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03124082</url>
  </required_header>
  <id_info>
    <org_study_id>34477</org_study_id>
    <nct_id>NCT03124082</nct_id>
  </id_info>
  <brief_title>OFA - Opioid Free Anesthesia</brief_title>
  <acronym>OFA</acronym>
  <official_title>Study Protocol &quot;OFA: Opioid-Free Anesthesia&quot;.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Parma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Parma</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Opioids have been used for analgesia since many years, but despite potent analgesia they are
      also associated to side effects, including opioid induced Hyperalgesia (OIH).

      OIH in the surgical setting is debated, and may predispose patients to higher analgesic
      consumption in the preoperative period, and peripheral and central sensitization. The aim of
      the study is to compare remifentanil-based vs non opioid analgesia (clonidine, lidocaine,
      ketamine) for intraoperative management of patients undergoing laparoscopic left
      hemicolectomy, with the hypothesis that non- opiod treated patients will have lower morphine
      consumption in the first 24 hours after surgery. Peripheral and central hyperalgesia will be
      tested with Von Frey hairs and pin-prick to evaluate acute CNS (Central Nervous System)
      sensitization after surgery. Acute and persistent (1 and 3 months) pain will be registered,
      together with any side effect and parameters of surgical rehabilitation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 4, 2017</start_date>
  <completion_date type="Anticipated">March 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized double blind trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>analgesic consumption</measure>
    <time_frame>24 HOURS</time_frame>
    <description>morphine mg by PCA (Patient Controlled Analgesia)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>side effects</measure>
    <time_frame>4 days after surgery</time_frame>
    <description>nausea and vomiting, ileus, itching, shiver, hypotension, bradycardia, sedation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score on the Visual Analog Scale</measure>
    <time_frame>3 months</time_frame>
    <description>VAS (Visual Analog Scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>peripheral sensitization</measure>
    <time_frame>24 hours</time_frame>
    <description>assessment of primary hyperalgesia by Von Frey Filaments at 24 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>central sensitization</measure>
    <time_frame>24 hours</time_frame>
    <description>assessment of secondary hyperalgesia by pin-prick test at 24 hours</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>opioid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>remifentanil 0,15-0,25 mcg/kg/h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>opioid free</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ketamine bolus 0,5 mg/kg + infusion 0,25 mg/kg/h lidocaine bolus 1 mg/kg + infusion 1 mg/kg/h clonidine 4 mcg/kg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <description>continuous infusion intraop</description>
    <arm_group_label>opioid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>bolus 0,5 mg/kg + infusion 0,25 mg/kg/h</description>
    <arm_group_label>opioid free</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>lidocaine bolus 1 mg/kg + infusion 1 mg/kg/h</description>
    <arm_group_label>opioid free</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clonidine</intervention_name>
    <description>clonidine 4 mcg/kg</description>
    <arm_group_label>opioid free</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  left hemicolectomy

          -  signed informed consent

          -  &gt;18 ys

        Exclusion Criteria:

          -  &gt;90 ys &lt;18 ys

          -  no consent

          -  pregnancy

          -  psychiatric disease

          -  cardiac failure, aortic or mitral valve severe stenosis

          -  kidney or hepatic failure

          -  atrio-ventricular type II block

          -  immunodepression

          -  emergency surgery

          -  ICU admittance

          -  drug or alcohol abuse

          -  chronic pain
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bugada Dario, MD</last_name>
    <phone>+390521703567</phone>
    <email>dariobugada@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Parma</city>
        <zip>43100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bugada Dario, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 22, 2017</study_first_submitted>
  <study_first_submitted_qc>April 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2017</study_first_posted>
  <last_update_submitted>April 18, 2017</last_update_submitted>
  <last_update_submitted_qc>April 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Parma</investigator_affiliation>
    <investigator_full_name>Massimo Allegri</investigator_full_name>
    <investigator_title>MD, Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Clonidine</mesh_term>
    <mesh_term>Analgesics, Opioid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

